← Back to Analyst Consensus 
PHVS Buy
Pharvaris N.V.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | B of A Securities | upgrade | Neutral → Buy | — | 53% |
| Sep 10, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Sep 9, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Sep 9, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Sep 9, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Sep 9, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 9, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Sep 9, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Sep 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 8, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Aug 13, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 13, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jul 15, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Jun 25, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 13, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Apr 9, 2026 | Wolfe Research | initiate | — → Outperform | — | 53% |
| Apr 7, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Apr 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Mar 9, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| Mar 3, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Dec 4, 2025 | Oppenheimer | maintain | Outperform → Outperform | $50 | 52% |
| Dec 4, 2025 | Guggenheim | maintain | Buy → Buy | $39 | 52% |
| Dec 4, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $41 | 54% |
| Dec 4, 2025 | B of A Securities | maintain | Neutral → Neutral | $30 | 53% |
| Dec 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Nov 14, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $37 | 54% |
| Nov 13, 2025 | Wedbush | maintain | Outperform → Outperform | $30 | 58% |
| Nov 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Oct 15, 2025 | HC Wainwright & Co. | initiate | — → Buy | $60 | 44% |
| Oct 9, 2025 | B of A Securities | upgrade | Underperform → Neutral | $27 | 53% |
| Aug 13, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $52 | 53% |
| Jun 5, 2025 | Wedbush | reiterate | Outperform → Outperform | $27 | 58% |
| May 14, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $25 | 50% |
| May 14, 2025 | Wedbush | maintain | Outperform → Outperform | $27 | 58% |
| Apr 29, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $28 | 50% |
| Mar 3, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $55 | 49% |
| Jan 31, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $55 | 53% |
| Sep 19, 2024 | Jones Trading | initiate | — → Buy | $46 | 50% |
| Sep 6, 2024 | Oppenheimer | maintain | Outperform → Outperform | $42 | 52% |
| Jul 3, 2024 | Oppenheimer | maintain | Outperform → Outperform | $38 | 52% |
| May 9, 2024 | Wedbush | maintain | Outperform → Outperform | $31 | 58% |
| Apr 22, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $34 | 54% |
| Apr 15, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $34 | 54% |
| Apr 11, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $50 | 53% |
| Apr 11, 2024 | Wedbush | reiterate | Outperform → Outperform | $35 | 58% |
| Mar 19, 2024 | Wedbush | reiterate | Outperform → Outperform | $35 | 58% |
| Mar 2, 2021 | B of A Securities | initiate | — → Neutral | $41 | 53% |
| Mar 2, 2021 | Oppenheimer | initiate | — → Outperform | $48 | 52% |
| Mar 2, 2021 | Morgan Stanley | maintain | — → Overweight | $51 | 54% |
Price Target Trend
Jun 23, 2026 Latest: $57.57 Oct 24, 2026
EPS Estimates
+1q $-0.77
Lo: $-0.90 Hi: $-0.66
11 analysts +1y $-2.72
Lo: $-3.53 Hi: $-2.11
12 analysts ▲2
0q $-0.72
Lo: $-0.80 Hi: $-0.67
11 analysts ▲1
0y $-2.77
Lo: $-3.01 Hi: $-2.39
13 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days